Martínez
Ángel Martínez, Barcelona Barcelona ES
Patent application number | Description | Published |
---|---|---|
20120249631 | RECOVERY PRINT MODE - In one embodiment, first printing is caused in response to a print job, applying ink upon a media utilizing a first row of printheads and a second row of printheads. The first row of printheads includes a plurality of printhead types. The second row of printheads is adjacent to the first row and includes at least one printhead of each of types. Failure of a first printhead within the first row is detected. The status of printheads included within the second row is analyzed. Second printing is caused applying ink upon the media utilizing the second row of printheads, and not the first row of printheads, in response to determining that printheads within the second row are operable to complete the print job. | 10-04-2012 |
Anna Sola Martínez, Zaragoza ES
Patent application number | Description | Published |
---|---|---|
20130101565 | USE OF CARBONIC ANHYDRASE II FOR PRODUCING A DRUG - The present invention falls within the field of biomedicine. Specifically, the present invention relates to the use of carbonic anhydrase II for the manufacture of a medicament for the prevention and/or treatment of the damage caused by ischemia, ischemia followed by reperfusion or toxins, acute failure or rejection of a transplanted organ, preferably the kidney. In a preferred embodiment, the toxin is cisplatin. | 04-25-2013 |
Antonio Martínez, Vizcaya ES
Patent application number | Description | Published |
---|---|---|
20110053793 | METHODS AND PRODUCTS FOR IDENTIFYING STRAINS OF BACTERIA - Methods for identifying strains of bacteria, particularly methods for serotyping | 03-03-2011 |
Antonio Martínez, Vizcaya ES
Patent application number | Description | Published |
---|---|---|
20110053793 | METHODS AND PRODUCTS FOR IDENTIFYING STRAINS OF BACTERIA - Methods for identifying strains of bacteria, particularly methods for serotyping | 03-03-2011 |
Antonio Martínez Martínez, Laukariz ES
Patent application number | Description | Published |
---|---|---|
20090209431 | Non-Invasive in Vitro Method to Detect Transitional Cell Carcinoma of the Bladder - The present invention refers to a non-invasive in vitro method to detect a transitional cell carcinoma of the bladder in an individual via urine analysis, to determine the stage or severity of this cancer in an individual or to monitor the effect of treatment administered to an individual suffering from this cancer. | 08-20-2009 |
20100087441 | Prognostic Method - A method for prognosing a rheumatoid arthritis phenotype using the outcomes of selected single nucleotide polymorphisms (SNPs) and clinical variables. A method for genotyping multiple rheumatoid arthritis associated genetic variations comprising use of a DNA microrarray. A microarray for use in the described methods. | 04-08-2010 |
Antonio Martínez Martínez, Laukariz ES
Patent application number | Description | Published |
---|---|---|
20100087441 | Prognostic Method - A method for prognosing a rheumatoid arthritis phenotype using the outcomes of selected single nucleotide polymorphisms (SNPs) and clinical variables. A method for genotyping multiple rheumatoid arthritis associated genetic variations comprising use of a DNA microrarray. A microarray for use in the described methods. | 04-08-2010 |
Carlos Serafin Pérez Martínez, Ciudad De La Habana CU
Patent application number | Description | Published |
---|---|---|
20120321560 | Method for Obtaining Novel Derivatives of Naphthalene for the In Vivo Diagnosis of Alzheimer's Disease - This invention relates to a chemistry branch, particularly to the field of compounds' organic synthesis that belongs to the aromatic bicyclic or naphthalene category, used in the detection of amyloid sheets. These new naphthalene derivatives have a general formula: Wherein R represents mutually independent groups. In I: R | 12-20-2012 |
Fernando De La Torre Martínez, Madrid ES
Patent application number | Description | Published |
---|---|---|
20090297564 | Use of a Liquid Allergy Vaccine Formulation for Oromucosal Administration - The present invention relates to the use of an allergen for the manufacture of a liquid vaccine formulation for preventing or treating allergy in a subject by oromucosal administration in a dosage regimen comprising no up-dosing. | 12-03-2009 |
Fernando De La Torre Martínez, Madrid ES
Patent application number | Description | Published |
---|---|---|
20090297564 | Use of a Liquid Allergy Vaccine Formulation for Oromucosal Administration - The present invention relates to the use of an allergen for the manufacture of a liquid vaccine formulation for preventing or treating allergy in a subject by oromucosal administration in a dosage regimen comprising no up-dosing. | 12-03-2009 |
Ignacio González Martínez, Mexico MX
Patent application number | Description | Published |
---|---|---|
20110290657 | Process for gold and silver leaching with thiourea solutions - A solution composition that permits the use of thiourea is provided. The process is to form a solution that improves, on one hand, the velocity of gold and silver extraction, from minerals and other materials that contain them, improving the stability of the thiourea in the leaching solution and, on the other, the direct electrorecovery of the metals from the solution. The leaching solution, beforehand or simultaneously, has been subjected to a controlled electro-oxidation to produce formamidine disulfide (FADS) which acts as an oxidizing agent for the mineral phases that contain the gold and silver. In a preferred mode, the FADS is present as 10 to 30% of the total thiourea contained in the solution and the electrodeposition of the metals is performed in the same cell (cathodic compartment) in which the FADS is formed (anodic compartment). | 12-01-2011 |
Jesús Manuel Martínez, Nuevo Leon MX
Patent application number | Description | Published |
---|---|---|
20110045299 | METHOD FOR PRODUCING STABLE, MONODISPERSED, NANOMETRIC MAGNESIUM HYDROXIDE AND RESULTING PRODUCT - The present invention refers to a method to prepare nanometric magnesium hydroxide particles. These particles have an average diameter that ranges from 90 to 110 nm, and that could range from 20 to 160 nm, with monodisperse and stable characteristics for greater than 12 month in a wide range of concentrations. This process includes 3 stages: one reaction stage performed in two steps, one of maturation and one of purification. The first step of the reaction is developed in micro blending zone, and the second one is the stabilization of suspension. During the second stage, the particles maturation is developed through a chemical-mechanic treatment. The last stage is designed to purify and concentrate the material, as well as its preparation to integrate it to the desired form. The obtained particles are re-dispersable in different means, such as water, aldehyde resins, phenolic resins, nitrocellulose, polyurethane, vinylic, acrylic, alcohol, and wide variety of organic materials and polymers such as high and low density polypropylene, Nylon, ABS and/or any combination of the same | 02-24-2011 |
Jesús Manuel Martínez, Nuevo Leon MX
Patent application number | Description | Published |
---|---|---|
20110045299 | METHOD FOR PRODUCING STABLE, MONODISPERSED, NANOMETRIC MAGNESIUM HYDROXIDE AND RESULTING PRODUCT - The present invention refers to a method to prepare nanometric magnesium hydroxide particles. These particles have an average diameter that ranges from 90 to 110 nm, and that could range from 20 to 160 nm, with monodisperse and stable characteristics for greater than 12 month in a wide range of concentrations. This process includes 3 stages: one reaction stage performed in two steps, one of maturation and one of purification. The first step of the reaction is developed in micro blending zone, and the second one is the stabilization of suspension. During the second stage, the particles maturation is developed through a chemical-mechanic treatment. The last stage is designed to purify and concentrate the material, as well as its preparation to integrate it to the desired form. The obtained particles are re-dispersable in different means, such as water, aldehyde resins, phenolic resins, nitrocellulose, polyurethane, vinylic, acrylic, alcohol, and wide variety of organic materials and polymers such as high and low density polypropylene, Nylon, ABS and/or any combination of the same | 02-24-2011 |
Rafael Vazquez Martínez, Cordoba ES
Patent application number | Description | Published |
---|---|---|
20120003252 | ISOFORMS OF HUMAN SOMATOSTATIN RECEPTOR TYPE 5 PRODUCED BY ALTERNATIVE PROCESSING AND OLIGO-NUCLEOTIDE PAIRS FOR DETECTION THEREOF BY PCR - The present invention concerns two human nucleic acids comprising sequences which code two novel isoforms of human somatostatin receptor type 5 produced by alternative adjustment, called sst5B and sst5C and with possible uses in tumoral processes. Additionally, the invention concerns oligonucleotide pairs used for the differential detection of said isoforms by means of the PCR technique in different tissues. | 01-05-2012 |
20130089867 | ISOFORMS OF THE HUMAN SST5 RECEPTOR ORIGINATED BY ALTERNATIVE SPLICING AND OLIGONUCLEOTIDE PAIRS TO DETECT THEM BY PCR - The present invention is referred to two human nucleic acids that comprise sequences encoding two new isoforms of the human somatostatin receptor type 5 originated by alternative splicing, named sst5B and sst5C, with possible involvement in tumor processes. In addition, the invention is referred to oligonucleotide pairs allowing their differential detection in several tissues using the PCR technique. | 04-11-2013 |
20140248628 | ISOFORMS OF THE HUMAN SST5 RECEPTOR ORIGINATED BY ALTERNATIVE SPLICING AND OLIGONUCLEOTIDE PAIRS TO DETECT THEM BY PCR - The present invention is referred to two human nucleic 5 acids that comprise sequences encoding two new isoforms of the human somatostatin receptor type 5 originated by alternative splicing, named sst5B and sst5C, with possible involvement in tumor processes. In addition, the invention is referred to oligonucleotide pairs allowing 10 their differential detection in several tissues using the PCR technique. | 09-04-2014 |
Rafael Vazquez Martínez, Cordoba ES
Patent application number | Description | Published |
---|---|---|
20120003252 | ISOFORMS OF HUMAN SOMATOSTATIN RECEPTOR TYPE 5 PRODUCED BY ALTERNATIVE PROCESSING AND OLIGO-NUCLEOTIDE PAIRS FOR DETECTION THEREOF BY PCR - The present invention concerns two human nucleic acids comprising sequences which code two novel isoforms of human somatostatin receptor type 5 produced by alternative adjustment, called sst5B and sst5C and with possible uses in tumoral processes. Additionally, the invention concerns oligonucleotide pairs used for the differential detection of said isoforms by means of the PCR technique in different tissues. | 01-05-2012 |